NEW YORK, Nov. 9, 2020 /PRNewswire/ — The following statement is being issued by Monteverde & Associates PC in regard to a proposed class action settlement.
SUMMARY NOTICE
|
TO: |
ALL RECORD HOLDERS AND ALL BENEFICIAL HOLDERS OF ENVISION HEALTHCARE CORPORATION (“ENVISION”) COMMON STOCK WHO PURCHASED, SOLD OR HELD SUCH STOCK DURING THE PERIOD FROM AND INCLUDING AUGUST 10, 2018, THE RECORD DATE FOR VOTING ON ENTERPRISE PARENT HOLDINGS INC.’S ACQUISITION OF ENVISION FOR $46.00 PER SHARE IN CASH (THE “ACQUISITION”), THROUGH AND INCLUDING OCTOBER 11, 2018, THE DATE THE ACQUISITION CLOSED, INCLUDING ANY AND ALL OF THEIR RESPECTIVE PREDECESSORS, SUCCESSORS, TRUSTEES, EXECUTORS, ADMINISTRATORS, ESTATES, LEGAL REPRESENTATIVES, HEIRS, ASSIGNS AND TRANSFEREES. |
YOU ARE HEREBY NOTIFIED, pursuant to an Order of the United States District Court for the District of Delaware, that a hearing will be held on February 16, 2021, at 10:00 a.m., before the Honorable Richard G. Andrews. Settlement Class Members should check the Settlement Class website in advance of the Final Approval Hearing to determine whether that hearing will occur in person at the United States District Court for the District of Delaware, J. Caleb Boggs Federal Building, 844 N King Street, Wilmington, DE 19801 or via a remote link. The hearing will be held for the purpose of determining: (1) whether the proposed Settlement of the Litigation for $17.4 million should be approved by the Court as fair, reasonable, and adequate; (2) whether a Final Judgment and Order of Dismissal with Prejudice should be entered by the Court dismissing the Litigation with prejudice and releasing the Released Claims against Defendants and Defendants’ Released Persons; (3) whether final certification of the Settlement Class, Lead Plaintiff, and Lead Counsel should be granted; (4) whether the Plan of Allocation for the Net Settlement Fund is fair, reasonable, and adequate and should be approved; and (5) whether the application of Lead Counsel for the payment of attorneys’ fees and expenses, and any award to Lead Plaintiff pursuant to 15 U.S.C. §78u-4(a)(4) should be approved.
IF YOU PURCHASED, SOLD OR HELD ENVISION COMMON STOCK DURING THE PERIOD FROM AND INCLUDING AUGUST 10, 2018 THROUGH AND INCLUDING OCTOBER 11, 2018 (THE “SETTLEMENT CLASS PERIOD”), YOUR RIGHTS MAY BE AFFECTED BY THE SETTLEMENT OF THIS LITIGATION, INCLUDING THE RELEASE AND EXTINGUISHMENT OF CLAIMS YOU MAY POSSESS RELATING TO YOUR PURCHASE OR ACQUISITION OF ENVISION COMMON STOCK DURING THE SETTLEMENT CLASS PERIOD.
If you have not received a detailed Notice of Pendency and Proposed Settlement of Class Action (“Notice”) and a copy of the Proof of Claim and Release form, you may obtain copies by writing to Envision Securities Litigation, Claims Administrator, 1-888-905-0951, or on the Internet at www.EnvisionMergerSettlement.com. If you are a Settlement Class Member, in order to share in the distribution of the Net Settlement Fund, you must submit a Proof of Claim and Release by mail (postmarked no later than March 11, 2021), or online at www.EnvisionMergerSettlement.com www.envisionmergersettlement.com no later than March 11, 2021, establishing that you are entitled to recovery.
If you purchased or acquired Envision common stock during the Settlement Class Period and you desire to be excluded from the Settlement Class, you must submit a request for exclusion so that it is received no later than January 25, 2021, in the manner and form explained in the detailed Notice referred to above. All Members of the Settlement Class who do not timely and validly request exclusion from the Settlement Class will be bound by any judgment entered in the Litigation pursuant to the Stipulation of Settlement.
Any objection to the Settlement, the Plan of Allocation, Lead Counsel’s request for the payment of attorneys’ fees and expenses, and any award to Lead Plaintiff must be received by each of the following recipients via hard copy and email no later than January 25, 2021 and filed with the Clerk of the Court no later than February 9, 2021:
CLERK OF THE COURT
UNITED STATES DISTRICT COURT
DISTRICT OF DELAWARE
J. Caleb Boggs Federal Building
844 N King Street
Wilmington, DE 19801
Lead Counsel:
Monteverde & Associates PC
Juan E. Monteverde
The Empire State Building
350 Fifth Avenue, Suite 4405
New York, NY 10118
jmonteverde@monteverdelaw.com
Counsel for Defendants:
Simpson Thacher & Bartlett LLP
Peter E. Kazanoff
425 Lexington Avenue
New York, NY 10017
pkazanoff@stblaw.com
Wachtell, Lipton, Rosen & Katz
Rachelle Silverberg
51 W. 52nd Street
New York, NY 10019
RSilverberg@WLRK.com
PLEASE DO NOT CONTACT THE COURT OR THE CLERK’S OFFICE REGARDING THIS NOTICE. If you have any questions about the Settlement, you may contact Lead Counsel at the address listed above.
|
Dated: November 9, 2020 |
BY ORDER OF THE COURT UNITED STATES DISTRICT COURT DISTRICT OF DELAWARE |
Regulators authorized AstraZeneca’s coronavirus vaccine for use in adults throughout the European Union on Friday, amid criticism the bloc is not moving fast enough to vaccinate its population.
WASHINGTON (AP) — A former FBI lawyer was sentenced to probation for altering an email that the Justice Department relied on during its surveillance of an aide to President Donald Trump during the Russia investigation.
MADISON, Wis. (AP) — Democratic Gov. Tony Evers lashed out Friday at rival Republicans who tried to repeal his statewide mask mandate, saying killing the order would be a ridiculous move comparable to abolishing speed limits.
COLUMBIA, S.C. (AP) — As some conservatives in South Carolina celebrated getting a bill that would ban almost all abortions in the state past a legislative barrier and likely becoming law, they said they are not finished trying to end all abortions.
A Moscow court on Friday put the brother and several allies of Russian opposition leader Alexei Navalny under house arrest for two months as authorities sought to stymie more protests over the jailing of the top Kremlin foe.